Brain chemical booster may unlock secrets of learning
NCT ID NCT07239791
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a low-dose drug that increases noradrenaline (a brain chemical) affects learning in 160 healthy adults. Participants will take either the drug or a placebo and perform tasks that measure how they learn from new information. The goal is to better understand the brain's learning processes, which could help with conditions like ADHD or depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NO DISEASE OR CONDITION IS BEING STUDIED are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut de Neuromodulation
RECRUITINGParis, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Power nap study: 25 minutes to sharper focus and less stress?
- Jump higher, run faster: plyometric training shows promise for young footballers
- Robotic surgery showdown: hand vs foot clutch in training
- CBG study: can this cannabis compound boost mood or memory?
- New online program aims to ease stress for korean american dementia caregivers
- Lab study aims to sharpen eye biopsy techniques